Article
[Prognosis value of thrombin activatable fibrinolysis inhibitor concentration and C1040T polymorphism in acute myocardial infarction treated with fibrinolysis].
Medicina intensiva - 1 Nov 2010
González F J, Caturla J M, Fernández M, Carrasco R, Marco P, Sánchez J, Benlloch S
Abstract excerpt
OBJECTIVE: To analyze the prognostic value of thrombin activatable fibrinolysis inhibitor (TAFI) and C1040T polymorphism in acute myocardial infarction treated with fibrinolysis. To analyze C1040T polymorphism influence on its plasma level. DESIGN: An observational, prospective study performed from November 2003 to November 2005 and with a 3 month follow-up. SETTING: Intensive Medicine Service from a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
